ALX Oncology Holdings Inc. Common Stock ALXO
$2.08
+5.58%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | 4 | 2026-08-18 | View → |
| 4 | 4 | 2026-08-18 | View → |
| 10-Q | 10-Q | 2026-08-06 | View → |
| 8-K | 8-K | 2026-08-06 | View → |
| 4 | 4 | 2026-07-06 | View → |
| 8-K | 8-K | 2026-06-30 | View → |
| 8-K | 8-K | 2026-06-26 | View → |
| 8-K | 8-K | 2026-06-11 | View → |
| 10-Q | 10-Q | 2026-05-08 | View → |
| 8-K | 8-K | 2026-05-08 | View → |
| DEF 14A | DEF 14A | 2026-04-20 | View → |
| 4 | 4 | 2026-04-17 | View → |
| 4 | 4 | 2026-04-17 | View → |
| 8-K | 8-K | 2026-04-13 | View → |
| 4 | 4 | 2026-03-23 | View → |
| 4 | 4 | 2026-03-23 | View → |
| 10-K | 10-K | 2026-03-09 | View → |
| 4 | 4 | 2026-03-05 | View → |
| 8-K | 8-K | 2026-02-27 | View → |
| 4 | 4 | 2026-02-20 | View → |
| 4 | 4 | 2026-02-19 | View → |
| 4 | Insider transaction | 2026-02-04 | View → |
| 424B5 | 424B5 | 2026-01-30 | View → |
| 8-K | 8-K | 2026-01-30 | View → |
| 8-K | 8-K | 2026-01-30 | View → |
| 4 | 4 | 2026-01-28 | View → |
| 4 | 4 | 2026-01-28 | View → |
| 4 | 4 | 2026-01-28 | View → |
| 8-K | 8-K | 2026-01-21 | View → |
| 4 | 4 | 2026-01-21 | View → |
| 4 | 4 | 2026-01-21 | View → |
| 4 | 4 | 2026-01-21 | View → |
| 4 | 4 | 2026-01-21 | View → |
| 4 | 4 | 2026-01-21 | View → |
| 4 | 4 | 2026-01-21 | View → |
| 4 | 4 | 2026-01-07 | View → |
| 10-Q | 10-Q | 2025-11-07 | View → |
| 8-K | 8-K | 2025-11-07 | View → |
| 4 | 4 | 2025-10-16 | View → |
| 4 | 4 | 2025-10-16 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $2.08
- Market Cap
- $272.41 million
- 52-Week Range
- $0.44 – $2.66
- Average Volume
- 1.01 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.